NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $80,092,533.10

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$120.24

▼ -4.09 (-3.29%)

As of 10/31/2024 02:24 PM ET

Days: 30 | 90 | 365

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894
9/12/2023	Gary A. Lyons	Director	Sell	5,000	$115.02	$575,100.00	203,697
9/1/2023	Gary A. Lyons	Director	Sell	5,000	$110.06	$550,300.00	203,697
9/1/2023	Julie Cooke	Insider	Sell	824	$110.93	$91,406.32	17,263
8/30/2023	David W. Boyer	Insider	Sell	2,733	$107.60	$294,070.80	3,460
8/28/2023	Ingrid Delaet	Insider	Sell	1,431	$107.52	$153,861.12	5,931
8/21/2023	Jude Onyia	Insider	Sell	3,198	$107.37	$343,369.26	9,638
8/21/2023	Kevin Charles Gorman	CEO	Sell	9,328	$107.40	$1,001,827.20	499,754
8/21/2023	Matt Abernethy	CFO	Sell	2,132	$107.39	$228,955.48	27,131
5/1/2023	Julie Cooke	Insider	Sell	11,397	$103.89	$1,184,034.33	16,169
5/1/2023	William H. Rastetter	Director	Sell	4,300	$101.43	$436,149.00	42,785
4/24/2023	Eiry Roberts	Insider	Sell	14,400	$103.48	$1,490,112.00	26,644
4/21/2023	William H. Rastetter	Director	Sell	6,034	$105.04	$633,811.36	39,460
4/19/2023	William H. Rastetter	Director	Sell	903	$105.00	$94,815.00	34,729
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/8/2023	Eric Benevich	Insider	Sell	980	$104.12	$102,037.60	34,381
2/8/2023	Kevin Charles Gorman	CEO	Sell	2,274	$104.30	$237,178.20	491,365
2/7/2023	Matt Abernethy	CFO	Sell	26,328	$102.40	$2,695,987.20	24,333
2/6/2023	Eric Benevich	Insider	Sell	1,280	$105.63	$135,206.40	17,879
2/6/2023	Kevin Charles Gorman	CEO	Sell	3,040	$105.68	$321,267.20	468,008
1/31/2023	Eiry Roberts	Insider	Sell	1,457	$109.99	$160,255.43	26,171
1/31/2023	Kevin Charles Gorman	CEO	Sell	2,707	$110.08	$297,986.56	465,278
1/31/2023	Matt Abernethy	CFO	Sell	1,283	$109.98	$141,104.34	21,357
1/6/2023	Eric Benevich	Insider	Sell	400	$125.00	$50,000.00	15,643
1/3/2023	Stephen A. Sherwin	Director	Sell	30,000	$118.86	$3,565,800.00	25,055
11/30/2022	Eric Benevich	Insider	Sell	50,000	$125.90	$6,295,000.00	15,643
11/10/2022	Eric Benevich	Insider	Sell	100	$125.36	$12,536.00	15,643
11/8/2022	Eric Benevich	Insider	Sell	24,593	$125.33	$3,082,240.69	15,643
11/3/2022	Darin Lippoldt	Insider	Sell	4,518	$125.02	$564,840.36	29,234
11/1/2022	Darin Lippoldt	Insider	Sell	10,000	$120.09	$1,200,900.00	29,234
10/31/2022	Gary A. Lyons	Director	Sell	15,000	$114.76	$1,721,400.00	203,697
10/27/2022	Darin Lippoldt	Insider	Sell	4,923	$115.04	$566,341.92	29,234
10/17/2022	Eric Benevich	Insider	Sell	4,960	$110.82	$549,667.20	15,643
10/4/2022	Gary A. Lyons	Director	Sell	5,000	$110.54	$552,700.00	203,697
10/3/2022	David W. Boyer	Insider	Sell	1,437	$106.59	$153,169.83	4,214
8/12/2022	Malcolm Lloyd-Smith	Insider	Sell	21,533	$105.95	$2,281,421.35	18,888
6/27/2022	Julie Cooke	Insider	Sell	754	$100.00	$75,400.00	16,918
5/9/2022	Richard F. Pops	Director	Sell	15,000	$76.30	$1,144,500.00	29,512
4/25/2022	Gary A. Lyons	Director	Sell	15,000	$92.76	$1,391,400.00	208,697
4/1/2022	William H. Rastetter	Director	Sell	10,728	$94.93	$1,018,409.04	34,022
3/22/2022	Darin Lippoldt	Insider	Sell	8,455	$95.05	$803,647.75
3/18/2022	Darin Lippoldt	Insider	Sell	300	$95.00	$28,500.00
2/7/2022	David W. Boyer	Insider	Sell	240	$81.07	$19,456.80
2/7/2022	Kevin Charles Gorman	CEO	Sell	8,710	$80.82	$703,942.20
2/7/2022	Matt Abernethy	CFO	Sell	3,310	$80.79	$267,414.90
1/24/2022	Stephen A. Sherwin	Director	Sell	15,000	$74.43	$1,116,450.00
1/10/2022	Eiry Roberts	Insider	Sell	2,632	$74.50	$196,084.00
1/5/2022	Kyle Gano	Insider	Sell	28,266	$85.50	$2,416,743.00
12/1/2021	Matt Abernethy	CFO	Sell	1,645	$82.59	$135,860.55

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/30/2024	Amalgamated Bank	50,530	$5.82M	0.0%	-3.0%	0.050%
10/30/2024	AlphaCentric Advisors LLC	22,500	$2.59M	1.9%	+221.4%	0.022%
10/30/2024	Gulf International Bank UK Ltd	7,695	$0.89M	0.0%	-4.6%	0.008%
10/30/2024	Impax Asset Management Group plc	85,000	$9.79M	0.0%	+70.0%	0.084%
10/30/2024	QRG Capital Management Inc.	18,279	$2.11M	0.0%	+3.2%	0.018%
10/30/2024	Asset Management One Co. Ltd.	69,230	$7.98M	0.0%	+2.5%	0.069%
10/29/2024	Robeco Institutional Asset Management B.V.	387,282	$44.62M	0.1%	+16.0%	0.384%
10/29/2024	Van ECK Associates Corp	83,582	$9.62M	0.0%	-13.1%	0.083%
10/29/2024	Janney Montgomery Scott LLC	16,395	$1.89M	0.0%	-2.5%	0.016%
10/28/2024	New York State Common Retirement Fund	179,774	$20.71M	0.0%	-13.7%	0.178%
10/28/2024	Rice Hall James & Associates LLC	117,417	$13.53M	0.7%	-0.6%	0.117%
10/28/2024	US Bancorp DE	3,864	$0.45M	0.0%	-30.7%	0.004%
10/25/2024	First Trust Direct Indexing L.P.	4,708	$0.54M	0.0%	+5.9%	0.005%
10/25/2024	New York State Teachers Retirement System	115,050	$13.26M	0.0%	+1.8%	0.114%
10/25/2024	China Universal Asset Management Co. Ltd.	19,421	$2.24M	0.2%	+64.3%	0.019%
10/25/2024	abrdn plc	136,424	$15.72M	0.0%	-15.3%	0.135%
10/25/2024	Pallas Capital Advisors LLC	6,448	$0.75M	0.0%	+108.1%	0.006%
10/24/2024	Nisa Investment Advisors LLC	1,345	$0.16M	0.0%	-80.8%	0.001%
10/24/2024	Asahi Life Asset Management CO. LTD.	3,285	$0.38M	0.2%	N/A	0.003%
10/24/2024	First Financial Bankshares Inc	17,734	$2.04M	0.0%	+6.3%	0.018%
10/24/2024	State of Alaska Department of Revenue	11,735	$1.35M	0.0%	+7.3%	0.012%
10/24/2024	DekaBank Deutsche Girozentrale	115,973	$13.23M	0.0%	+2.1%	0.115%
10/24/2024	Wealth Enhancement Advisory Services LLC	5,646	$0.65M	0.0%	-11.2%	0.006%
10/24/2024	Forsta AP Fonden	22,200	$2.56M	0.0%	-31.9%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	13,433	$1.55M	0.0%	+250.5%	0.013%
10/23/2024	Louisiana State Employees Retirement System	28,000	$3.23M	0.1%	-1.8%	0.028%
10/23/2024	Mediolanum International Funds Ltd	59,902	$6.88M	0.1%	+30.0%	0.060%
10/23/2024	Assenagon Asset Management S.A.	29,803	$3.43M	0.0%	-88.1%	0.030%
10/23/2024	Hennion & Walsh Asset Management Inc.	9,580	$1.10M	0.1%	+42.0%	0.010%
10/22/2024	Lecap Asset Management Ltd.	8,072	$0.93M	0.2%	+42.6%	0.008%
10/22/2024	Stanley Laman Group Ltd.	37,531	$4.32M	0.6%	+36.8%	0.037%
10/22/2024	Signaturefd LLC	2,636	$0.30M	0.0%	-3.2%	0.003%
10/19/2024	Allspring Global Investments Holdings LLC	689,986	$79.50M	0.1%	-2.9%	0.686%
10/18/2024	Raymond James & Associates	62,446	$7.20M	0.0%	+4.3%	0.062%
10/18/2024	Blue Trust Inc.	348	$40K	0.0%	+171.9%	0.000%
10/17/2024	Trust Point Inc.	1,935	$0.22M	0.0%	+22.0%	0.002%
10/17/2024	Sumitomo Mitsui DS Asset Management Company Ltd	11,218	$1.29M	0.0%	-1.9%	0.011%
10/16/2024	nVerses Capital LLC	3,400	$0.39M	0.2%	N/A	0.003%
10/16/2024	Vontobel Holding Ltd.	14,590	$1.68M	0.0%	+12.7%	0.014%
10/15/2024	Washington Capital Management Inc.	5,100	$0.59M	0.5%	+54.5%	0.005%
10/11/2024	Creative Planning	12,999	$1.50M	0.0%	+12.3%	0.013%
10/11/2024	Redhawk Wealth Advisors Inc.	9,639	$1.11M	0.2%	+9.1%	0.010%
10/10/2024	Exchange Traded Concepts LLC	7,964	$0.92M	0.0%	+29.3%	0.008%
10/10/2024	Inspire Investing LLC	2,469	$0.28M	0.0%	-45.4%	0.002%
10/10/2024	Livforsakringsbolaget Skandia Omsesidigt	3,800	$0.44M	0.0%	+26.7%	0.004%
10/9/2024	Juncture Wealth Strategies LLC	8,398	$0.97M	0.4%	-2.3%	0.008%
10/9/2024	Tobam	73,246	$8.44M	1.6%	-19.0%	0.073%
10/9/2024	Sendero Wealth Management LLC	20,272	$2.34M	0.4%	+2.7%	0.020%
10/9/2024	Perpetual Ltd	12,560	$1.45M	0.0%	+96.6%	0.012%
10/8/2024	CWM LLC	7,884	$0.91M	0.0%	+15.1%	0.008%
10/8/2024	FCF Advisors LLC	10,574	$1.22M	0.3%	-4.2%	0.011%
10/8/2024	Tealwood Asset Management Inc.	11,793	$1.36M	0.6%	-0.9%	0.012%
10/7/2024	GAMMA Investing LLC	1,738	$0.20M	0.0%	+11.9%	0.002%
10/5/2024	Red Spruce Capital LLC	15,906	$1.83M	0.8%	-1.5%	0.016%
10/5/2024	Handelsbanken Fonder AB	26,867	$3.10M	0.0%	+20.7%	0.027%
10/3/2024	Park Avenue Securities LLC	5,744	$0.66M	0.0%	-42.2%	0.006%
10/3/2024	SG Americas Securities LLC	8,084	$0.93M	0.0%	-81.0%	0.008%
10/2/2024	Central Pacific Bank Trust Division	4,902	$0.57M	0.1%	-32.3%	0.005%
10/2/2024	Massmutual Trust Co. FSB ADV	374	$43K	0.0%	-27.0%	0.000%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	20,271	$2.79M	0.0%	-6.4%	0.020%
9/5/2024	Sanctuary Advisors LLC	3,751	$0.51M	0.0%	N/A	0.004%
8/22/2024	Aurora Investment Counsel	10,437	$1.44M	0.8%	-1.1%	0.010%
8/22/2024	Cetera Investment Advisers	7,112	$0.98M	0.0%	+7.9%	0.007%
8/21/2024	Truist Financial Corp	31,546	$4.34M	0.0%	-15.5%	0.031%
8/16/2024	Perceptive Advisors LLC	649,909	$89.47M	2.1%	-19.2%	0.646%
8/16/2024	Northwestern Mutual Wealth Management Co.	757	$0.10M	0.0%	-92.9%	0.001%
8/16/2024	Driehaus Capital Management LLC	71,295	$9.82M	0.1%	-0.4%	0.071%
8/15/2024	Susquehanna Portfolio Strategies LLC	59,455	$8.19M	0.3%	-48.2%	0.059%
8/15/2024	Susquehanna Fundamental Investments LLC	3,695	$0.51M	0.0%	N/A	0.004%
8/15/2024	Scientech Research LLC	1,516	$0.21M	0.0%	-66.1%	0.002%
8/15/2024	Lion Point Capital LP	8,350	$1.15M	2.1%	+11.3%	0.008%
8/15/2024	Mackenzie Financial Corp	88,827	$12.23M	0.0%	-3.2%	0.088%
8/15/2024	The Manufacturers Life Insurance Company	125,401	$17.26M	0.0%	+0.9%	0.125%
8/15/2024	MBB Public Markets I LLC	7,132	$0.98M	0.0%	N/A	0.007%
8/15/2024	Daymark Wealth Partners LLC	1,774	$0.24M	0.0%	+18.3%	0.002%
8/15/2024	DSM Capital Partners LLC	997,784	$137.37M	2.0%	-12.2%	0.991%
8/15/2024	APG Asset Management N.V.	257,315	$33.05M	0.1%	-31.8%	0.256%
8/15/2024	APG Asset Management US Inc.	27,953	$3.92M	0.0%	+2.6%	0.028%
8/15/2024	AQR Capital Management LLC	1,223,055	$166.96M	0.3%	+23.0%	1.215%
8/15/2024	Armistice Capital LLC	978,488	$134.71M	1.7%	-4.4%	0.972%
8/15/2024	AXA S.A.	284,022	$39.10M	0.1%	+16.6%	0.282%
8/15/2024	Caxton Associates LP	18,121	$2.50M	0.1%	-2.2%	0.018%
8/15/2024	Toronto Dominion Bank	9,553	$1.32M	0.0%	-4.1%	0.009%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	19,056	$2.62M	0.0%	+62.5%	0.019%
8/14/2024	Xponance Inc.	25,228	$3.47M	0.0%	-1.7%	0.025%
8/14/2024	Bank of Montreal Can	39,351	$5.42M	0.0%	-2.2%	0.039%
8/14/2024	Integral Health Asset Management LLC	70,000	$9.64M	0.9%	-53.3%	0.070%
8/14/2024	Hood River Capital Management LLC	243,897	$33.58M	0.7%	+7.0%	0.242%
8/14/2024	1832 Asset Management L.P.	541,200	$74.51M	0.1%	+1,370.7%	0.538%
8/14/2024	ProShare Advisors LLC	10,958	$1.51M	0.0%	-7.4%	0.011%
8/14/2024	Profund Advisors LLC	24,317	$3.35M	0.1%	+74.8%	0.024%
8/13/2024	Ensign Peak Advisors Inc	272,613	$37.53M	0.1%	+76.2%	0.271%
8/13/2024	Thrivent Financial for Lutherans	46,577	$6.41M	0.0%	+86.8%	0.046%
8/13/2024	Sei Investments Co.	128,016	$17.62M	0.0%	+47.7%	0.127%
8/13/2024	Pacer Advisors Inc.	31,890	$4.39M	0.0%	+76.1%	0.032%
8/13/2024	Skandinaviska Enskilda Banken AB publ	119,837	$16.50M	0.1%	+2.5%	0.119%
8/13/2024	Simplify Asset Management Inc.	22,834	$3.14M	0.2%	N/A	0.023%
8/13/2024	Canada Pension Plan Investment Board	66,449	$9.15M	0.0%	-64.8%	0.066%
8/13/2024	Public Employees Retirement Association of Colorado	11,113	$1.53M	0.0%	-3.9%	0.011%
8/12/2024	Intech Investment Management LLC	68,698	$9.46M	0.1%	+184.0%	0.068%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $120.24

$119.42

$123.04

50 Day Range

MA: $121.02

$111.62

$152.81

52 Week Range

Now: $120.24

$103.63

$157.98

Volume

487,453 shs

Average Volume

856,547 shs

Market Capitalization

$12.14 billion

P/E Ratio

36.33

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Kyle Gano (Insider)
William H Rastetter (Director)
Eric Benevich (Insider)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
Eiry Roberts (Insider)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Julie Cooke (Insider)
Jude Onyia (Insider)
Ingrid Delaet (Insider)
David W Boyer (Insider)
Shalini Sharp (Director)
George J Morrow (Director)
Leslie V Norwalk (Director)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Allspring Global Investments Holdings LLC — 0.69%
Robeco Institutional Asset Management B.V. — 0.38%
New York State Common Retirement Fund — 0.18%
abrdn plc — 0.14%
Rice Hall James & Associates LLC — 0.12%
DekaBank Deutsche Girozentrale — 0.12%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
SG Americas Securities LLC
New York State Common Retirement Fund
abrdn plc
Allspring Global Investments Holdings LLC
Tobam
Van ECK Associates Corp
Forsta AP Fonden
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Kyle Gano (Insider)
William H Rastetter (Director)
Eric Benevich (Insider)
Darin Lippoldt (Insider)
Matt Abernethy (CFO)
Eiry Roberts (Insider)
Richard F Pops (Director)
Stephen A Sherwin (Director)
Julie Cooke (Insider)
Jude Onyia (Insider)
Ingrid Delaet (Insider)
David W Boyer (Insider)
Shalini Sharp (Director)
George J Morrow (Director)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Robeco Institutional Asset Management B.V.
Impax Asset Management Group plc
AlphaCentric Advisors LLC
Mediolanum International Funds Ltd
Stanley Laman Group Ltd.
Mirae Asset Global Investments Co. Ltd.
China Universal Asset Management Co. Ltd.
Perpetual Ltd